71 results on '"Kruchko, Carol"'
Search Results
2. The impact of COVID-19 on 2020 monthly incidence trends of primary brain and other CNS tumors.
3. Association of county-level socioeconomic status with meningioma incidence and outcomes.
4. Childhood, adolescent, and adult primary brain and central nervous system tumor statistics for practicing healthcare providers in neuro-oncology, CBTRUS 2015–2019.
5. Brain tumors in United States military veterans.
6. The impact of the COVID-19 pandemic on treatment patterns in glioblastoma.
7. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016—2020.
8. The association of Medicaid expansion and pediatric cancer overall survival.
9. The joint impacts of sex and race/ethnicity on incidence of grade 1 versus grades 2-3 meningioma across the lifespan.
10. National-level overall survival patterns for molecularly-defined diffuse glioma types in the United States.
11. Molecular marker testing and reporting completeness for adult-type diffuse gliomas in the United States.
12. Incidence and survival of choroid plexus tumors in the United States.
13. Corrigendum to: Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States.
14. Influence of county-level geographic/ancestral origin on glioma incidence and outcomes in US Hispanics.
15. Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States.
16. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015–2019.
17. CBTRUS Statistical Report: Pediatric Brain Tumor Foundation Childhood and Adolescent Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018.
18. Aligning the Central Brain Tumor Registry of the United States (CBTRUS) histology groupings with current definitions.
19. population study of clinical trial accrual for women and minorities in neuro-oncology following the NIH Revitalization Act.
20. Primary brain and other central nervous system tumors in the United States (2014-2018): A summary of the CBTRUS statistical report for clinicians.
21. Epidemiology of pineoblastoma in the United States, 2000–2017.
22. Medicaid expansion is associated with increased 1-year survival for primary malignant brain tumors.
23. Importance of the intersection of age and sex to understand variation in incidence and survival for primary malignant gliomas.
24. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018.
25. Epidemiology of brainstem high-grade gliomas in children and adolescents in the United States, 2000-2017.
26. European genetic ancestry associated with risk of childhood ependymoma.
27. Ependymoma, NOS and anaplastic ependymoma incidence and survival in the United States varies widely by patient and clinical characteristics, 2000-2016.
28. Relative survival after diagnosis with a primary brain or other central nervous system tumor in the National Program of Cancer Registries, 2004 to 2014.
29. Association between urbanicity and surgical treatment among patients with primary glioblastoma in the United States.
30. Sex is an important prognostic factor for glioblastoma but not for nonglioblastoma.
31. Cancer collection efforts in the United States provide clinically relevant data on all primary brain and other CNS tumors.
32. Nonmalignant and malignant meningioma incidence and survival in the elderly, 2005–2015, using the Central Brain Tumor Registry of the United States.
33. Survivorship in adults with malignant brain and other central nervous system tumor from 2000–2014.
34. Pilocytic astrocytomas: where do they belong in cancer reporting?
35. The elderly left behind--changes in survival trends of primary central nervous system lymphoma over the past 4 decades.
36. The CBTRUS story: providing accurate population-based statistics on brain and other central nervous system tumors for everyone.
37. Global incidence of malignant brain and other central nervous system tumors by histology, 2003–2007.
38. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014.
39. Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010.
40. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013.
41. American Brain Tumor Association Adolescent and Young Adult Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.
42. Years of potential life lost for brain and CNS tumors relative to other cancers in adults in the United States, 2010.
43. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.
44. Corrigendum to: CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013–2017.
45. Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States.
46. Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007–2011.
47. The descriptive epidemiology of atypical teratoid/rhabdoid tumors in the United States, 2001–2010.
48. Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registries.
49. Glioblastoma incidence rate trends in Canada and the United States compared with England, 1995–2015.
50. Consensus Conference on Cancer Registration of Brain and Central Nervous System Tumors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.